Related Experiment Video
Updated: Apr 16, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
[Urinary incontinence induced by the antidepressants - case report]
Urinary incontinence in a patient was linked to the antidepressant mirtazapine. Discontinuation of mirtazapine resolved the incontinence, highlighting the need to consider drug interactions.
Area of Science:
- Pharmacology
- Urology
Background:
- Antidepressants can influence central nervous system neurotransmitters affecting lower urinary tract function.
- Mirtazapine is a commonly prescribed antidepressant with potential anticholinergic and alpha-adrenergic blocking effects.
Observation:
- A 55-year-old patient presented with urinary incontinence, initially considered for surgical intervention.
- Detailed history revealed mirtazapine use as a potential causative agent for the incontinence.
Findings:
- Discontinuation of mirtazapine led to complete resolution of urinary incontinence.
- This case demonstrates mirtazapine-induced urinary incontinence, a less common side effect.
Implications:
- Clinicians should consider antidepressant-induced urinary incontinence in differential diagnoses.
- Identifying drug-induced incontinence can prevent unnecessary surgical procedures and restore continence effectively.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
04:22Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Antidepressant Drugs: Overview
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Urinary Tract Infection IV: Nursing Management